Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticoagulation in Hospitalized Patients with Covid-19.

Literature DB >> 33085867

Anticoagulation in Hospitalized Patients with Covid-19.

Jehan F Chowdhury, Lisa K Moores, Jean M Connors.

Abstract

Entities: Disease Species

Mesh：

Substances：
Anticoagulants

Year: 2020 PMID： 33085867 DOI： 10.1056/NEJMclde2028217

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

25 in total

1. Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.

Authors: Sebastian Voicu; Benjamin G Chousterman; Philippe Bonnin; Nicolas Deye; Isabelle Malissin; Arthur Le Gall; Romain Barthélémy; Laetitia Sutterlin; Giulia Naim; Aymen Mrad; Adrien Pepin-Lehalleur; Matthieu Le Dorze; Charles de Roquetaillade; Jean-Michel Ekhérian; Etienne Gayat; Georgios Sidéris; Alexandre Mebazaa; Bruno Mégarbane
Journal: J Infect Date: 2020-11-20 Impact factor: 6.072

2. Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.

Authors: Jean-Philippe Kevorkian; Amanda Lopes; Damien Sène; Jean-Pierre Riveline; Claire Vandiedonck; Florine Féron; Kladoum Nassarmadji; Stéphane Mouly; Franck Mauvais-Jarvis; Jean-François Gautier; Bruno Mégarbane
Journal: J Infect Date: 2021-02-09 Impact factor: 6.072

3. Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study.

Authors: José Augusto Santos Pellegrini; Tatiana Helena Rech; Patrícia Schwarz; Ana Cláudia Tonelli de Oliveira; Tarsila Vieceli; Rafael Barberena Moraes; Leo Sekine; Marina Verçoza Viana
Journal: J Thromb Thrombolysis Date: 2021-02-18 Impact factor: 2.300

4. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis.

Authors: Matthew L Meizlish; George Goshua; Yiwen Liu; Rebecca Fine; Kejal Amin; Eric Chang; Nicholas DeFilippo; Craig Keating; Yuxin Liu; Michael Mankbadi; Dayna McManus; Stephen Wang; Christina Price; Robert D Bona; Cassius Iyad Ochoa Chaar; Hyung J Chun; Alexander B Pine; Henry M Rinder; Jonathan Siner; Donna S Neuberg; Kent A Owusu; Alfred Ian Lee
Journal: medRxiv Date: 2021-01-15

5. Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation.

Authors: Elvira Grandone; Giovanni Tiscia; Raffaele Pesavento; Antonio De Laurenzo; Davide Ceccato; Maria Teresa Sartori; Lucia Mirabella; Gilda Cinnella; Mario Mastroianno; Lidia Dalfino; Donatella Colaizzo; Roberto Vettor; Mariano Intrieri; Angelo Ostuni; Maurizio Margaglione
Journal: J Thromb Thrombolysis Date: 2021-04-12 Impact factor: 2.300

Anticoagulation in Hospitalized Patients with Covid-19.

1. Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.

2. Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.

3. Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study.

4. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis.

5. Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation.

6. Massive intraperitoneal hemorrhage in patients with COVID-19: a case series.

7. Essential inpatient otolaryngology: what COVID-19 has revealed.

Review 8. Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.

9. Pulmonary embolism severity before and during the COVID-19 pandemic.

10. Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection.